Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Medical oncology

Patients with brain metastases in early-phase trials

Nature Reviews Clinical Oncology volume 8, pages 390–391 (2011)Cite this article

Subjects

A recent publication presented objective evidence that patients with and without brain metastases perform similarly in phase I clinical trials for advanced-stage cancer. This finding supports what neurosurgeons and neuro-oncologists have long suspected; namely, that the presence of brain metastases need not mandate exclusion of patients from early-phase clinical trials.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Enrollment of patients with BM in phase I clinical trials for lung cancer.

References

  1. Chamberlain, M. C. Brain metastases: a medical neuro-oncology perspective. Expert Rev. Neurother. 10, 563–573 (2010).

    Article  PubMed  Google Scholar 

  2. Sperduto, P. W. et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int. J. Radiat. Oncol. Biol. Phys. 77, 655–661 (2010).

    Article  PubMed  Google Scholar 

  3. Horton, J., Baxter, D. H. & Olson, K. B. The management of metastases to the brain by irradiation and corticosteroids. Am. J. Roentgenol. Radium Ther. Nucl. Med. 111, 334–336 (1971).

    Article  CAS  PubMed  Google Scholar 

  4. Gaspar, L. et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys. 37, 745–751 (1997).

    Article  CAS  PubMed  Google Scholar 

  5. Patchell, R. A. et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280, 1485–1489 (1998).

    Article  CAS  PubMed  Google Scholar 

  6. Andrews, D. W. et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363, 1665–1672 (2004).

    Article  PubMed  Google Scholar 

  7. Marko, N. F. et al. Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases. World Neurosurg. 73, 186–193 (2010).

    Article  PubMed  Google Scholar 

  8. Tsimberidou, A. M. et al. Phase I clinical trials in 93 patients with brain metastases: the M. D. Anderson Cancer Center experience. Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-10-3095.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. US National Library of Medicine. ClinicalTrials.gov [online], (2011).

  10. Yap, T. A., Sandhu, S. K., Workman, P. & de Bono, J. S. Envisioning the future of early anticancer drug development. Nat. Rev. Cancer 10, 514–523 (2010).>

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This article was supported in part by Grant W81XWH-062-0033 from the US Department of Defense Breast Cancer Research Program to R. J. Weil. We wish to thank the Melvin Burkhardt Chair in Neurosurgical Oncology and the Karen Colina Wilson research endowment within the Burkhardt Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic Foundation for additional support and funding.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, The Cleveland Clinic Neurological Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, 44195, OH, USA

    Nicholas F. Marko

  2. Burkhardt Brain Tumor and Neuro-Oncology Center, The Cleveland Clinic Neurological Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, 44195, OH, USA

    Robert J. Weil

Authors
  1. Nicholas F. Marko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Weil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert J. Weil.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marko, N., Weil, R. Patients with brain metastases in early-phase trials. Nat Rev Clin Oncol 8, 390–391 (2011). https://doi.org/10.1038/nrclinonc.2011.73

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2011.73

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer